- Home
- Responsibility
- Funding external partners
Funding external partners
Medicines and vaccines bring significant benefits for individual patients and for public health. In order to bring these benefits we need to interact with external groups throughout the research, development and marketing of our medicines and vaccines. This enables us to use the expertise of patients, scientists, doctors and other healthcare professionals to better understand how to conduct the most effective research, how to make treatment advances and how to meet patient needs.
In some instances these interactions involve GSK providing funding to an organisation or an individual. We know these relationships can cause concern and we therefore aim to be transparent about the payments we make and what they are for.
Patient group funding
We publish information on all our work with patient groups in our US, Europe and Asia Pacific and Emerging Markets regions, as well as information on our support for patient groups working globally, including details of the funding received. See details of our funding for patient organisations.
Charitable giving
We publish information about our charitable giving in our Annual Report and Corporate Responsibility Report each year. We also publish details of our individual charitable grants over £10,000 ($20,000). Find out more about our grants.
Payments to healthcare professionals
We publish quarterly reports of payments made to healthcare professionals in the US for speaking and advisory services. We are working towards disclosing payments made to individual HCPs outside the US, however in the meantime we will publish aggregate 2010 payments made by our Pharmaceuticals and Consumer Healthcare businesses outside the US by the end of 2011.
Grants and donations to healthcare organisations
We publish quarterly reports of the grants and donations we make in the US. We are working towards disclosing individual healthcare organisation grants and donations outside the US, however in the meantime we will publish aggregate 2010 payments made by our Pharmaceuticals and Consumer Healthcare businesses by the end of 2011.
Payments to healthcare professionals and their institutions for conducting research
We will disclose research payments made in 2010 to US healthcare professionals and their institutions for research studies starting from January 2010 onwards. These figures will be published in the first half of 2011. Outside the US we will continue to work towards disclosure of individual payments. In the meantime we will publish payments on an aggregate basis, commencing with the publication in 2013 of payments made during 2012.
